logoTry Persana

Intelligencia AI - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Intelligencia AI including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Intelligencia AI company logo

Applying machine learning in drug development

Intelligencia AI uses artificial intelligence to de-risk drug development by estimating risk factors in clinical trials.

HeadquartersNew York, United States
Team size101-250
Founded2017

What is Intelligencia AI? - Company Overview & Details

Intelligencia AI is Intelligencia AI uses artificial intelligence to de-risk drug development by estimating risk factors in clinical trials. Founded in 2017, the company is headquartered in New York, United States.

Who Founded Intelligencia AI?

Intelligencia AI was founded by Dimitrios Skaltsas, Vangelis Vergetis.

Who are the Key Executives at Intelligencia AI? - Leadership Team

Intelligencia AI is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Intelligencia AI

Dimitrios SkaltsasCEO

Chief Technology Officer (CTO) of Intelligencia AI

CTO

About Dimitrios Skaltsas - CEO of Intelligencia AI

Dimitrios Skaltsas serves as the Chief Executive Officer of Intelligencia AI, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Intelligencia AI Company Details & Key Information

Where is Intelligencia AI located?

Intelligencia AI is headquartered in New York, United States.

How many employees does Intelligencia AI have?

Intelligencia AI has 101-250 employees.

When was Intelligencia AI founded?

Intelligencia AI was founded in 2017.

Intelligencia AI Official Website

How much funding has Intelligencia AI raised?

Intelligencia AI has raised $12 Million across 3 funding rounds. The most recent funding was completed on 2021-09-10.

Funding Overview

Intelligencia AI raised $12 million in funding to expand its clientele and product base.

$12 Million
Total Funding Raised
3
Funding Rounds
2021-09-10
Latest Round

Intelligencia AI Funding History

Series A
2021-09-10
$12 Million

Who are the key investors in Intelligencia AI?

Intelligencia AI is backed by 1 key investors including MTIP AG. These investors focus on Healthtech sectors.

Intelligencia AI Investor Overview

1
Key Investors
1
Focus Areas
0
Notable Investments

Complete List of Intelligencia AI Investors

MTIP AG

Investment company focusing on healthtech investments.

Investment Focus
Healthtech

What sectors do Intelligencia AI investors focus on?

The investors backing Intelligencia AI primarily focus on Healthtech sectors.

Healthtech

Featured Investor: MTIP AG

MTIP AG

Investment company focusing on healthtech investments.

Notable Investments:

What are Intelligencia AI's future plans?

Intelligencia AI Expand R&D team and develop sales operations in the USA and Europe.

Intelligencia AI Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Intelligencia AI face?

Intelligencia AI has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Intelligencia AI

1

Evaluating clinical trial risks

2

Scaling operations without overburdening the team

What opportunities does Intelligencia AI have?

Intelligencia AI has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Intelligencia AI

1

Integrating data into AI tools

2

Expanding service to more pharmaceutical companies

Intelligencia AI Strategic Position Summary

Key Focus Areas

Intelligencia AI is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Intelligencia AI?

Intelligencia AI has 2 recent news updates covering key business developments and market activities.

Intelligencia AI News Overview

2
Recent Articles
Active
Media Coverage
2024-03-19
Latest Update

What is Intelligencia AI in the news for?

Intelligencia AI is currently featured in news for Intelligencia recognized as No. 90 on inc. magazine's list of the Northeast region's fastest-growing private companies. and other significant business developments.

Recent News Articles About Intelligencia AI

Article 1
2024-03-19

Intelligencia recognized as No. 90 on inc. magazine's list of the Northeast region's fastest-growing private companies.

Intelligencia AI ranks No. 90 on inc. magazine's list of fastest-growing private companies in the Northeast.

tradingview.com
Read News
Article 2
2021-08-25

Intelligencia receives financing of $12M in funding.

Intelligencia raised $12 million to expand its clientele and product base.

emeastartups.com
Read News

Intelligencia AI FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Intelligencia AI including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Intelligencia AI Questions & Answers - Company Information

Q1

What is Intelligencia AI?

Intelligencia AI uses artificial intelligence to de-risk drug development by estimating risk factors in clinical trials.

Q2

Who founded Intelligencia AI?

Intelligencia AI was founded by Dimitrios Skaltsas, Vangelis Vergetis.

Q3

Who is the CEO of Intelligencia AI?

The CEO of Intelligencia AI is Dimitrios Skaltsas. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Intelligencia AI raised?

Intelligencia AI has raised a total of $$12 Million across 3 funding rounds. The most recent funding was completed on 2021-09-10.

Q5

Who are the investors in Intelligencia AI?

Intelligencia AI's key investors include MTIP AG.

Q6

Where is Intelligencia AI headquartered?

Intelligencia AI is headquartered in New York, United States.

Q7

When was Intelligencia AI founded?

Intelligencia AI was founded in 2017.

Q8

How many employees does Intelligencia AI have?

Intelligencia AI has 101-250 employees.

Q9

What is Intelligencia AI's official website?

You can visit Intelligencia AI's official website at intelligencia.ai.

Q10

What was Intelligencia AI's latest funding round?

Intelligencia AI's latest funding round was a Series A round of $$12 Million completed on 2021-09-10.

Q11

Who is founder?

Dimitrios Skaltsas

Q12

What does the company do?

Intelligencia AI uses artificial intelligence to de-risk drug development by estimating risk factors in clinical trials.

Q13

How much funding?

$12 Million

Q14

Latest funding date?

2021-09-10

Q15

Who are the investors?

MTIP AG

Q16

What are the challenges?

Evaluating clinical trial risks Scaling operations without overburdening the team

Q17

What are the opportunities?

Integrating data into AI tools Expanding service to more pharmaceutical companies

Q18

Latest news?

Intelligencia AI ranks No. 90 on inc. magazine's list of fastest-growing private companies in the Northeast. Intelligencia raised $12 million to expand its clientele and product base.

More Information About Intelligencia AI

For additional details about Intelligencia AI, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.